UAE Ministry recalls medicines, injections for safety reasons

Dubai - Two manufacturers have been asked to provide alternative supplies to avoid a shortage of products

The Ministry of Health and Prevention (MOHAP) has withdrawn a medical device and one batch of pharmaceutical products. 
The circular advised the withdrawal of a lot of the medical device NoNexcare Family Set with batch number 201809LT manufactured by 3M Gulf Ltd, following which the notice was given to the manufacturer.
The ministry issued a circular to directors of medical districts, government and private hospitals, doctors, pharmacists and assistant pharmacists to withdraw the sale and use of one batch of a medical device and one batch of a pharmaceutical product in accordance with the Ministerial decree No (366) 2010 concerning the announcement of withdrawal, suspension or prevention of distribution of pharmaceutical and medical products, said Dr Amin Hussein Al Amiri, Assistant Undersecretary for Public Health Policy and Licenses, Chairman of the Higher Pharmacovigilance Committee in the UAE.
The company stated that it has withdrawn the said product which is used for the covering and protection of small injuries and wounds expiring on September 2018 due to typographical errors. The correct batch number is 09LT9. 201.
The ministry also issued another circular to withdraw one lot of Miacin 500mg/2ml IV/IM Ampoules. The withdrawn batch number is D041, and the product is produced by Hikma Pharmaceuticals.
An analysis performed by the Quality Control and Research department at the ministry found that the product which is used in the treatment of bacterial infections and expiring on June 2018, contains visible particles in the injection.
Dr Al Amiri advised that all healthcare practitioners and patients should not use the above-mentioned medical products. He called on two manufacturers to provide alternative supplies to avoid a shortage of products. 
The Assistant Undersecretary urged the public to report any side effects by filling up the Adverse Drug Reaction (ADR) form available at http://www.cpd-pharma.ae, or contacting the following: Tel: 02-3201448, Fax: 02-3201947, or email: pv@moh.gov.ae. 
asmaalizain@khaleejtimes.com